Dicerna Pharma (DRNA) Tops Q3 EPS by 17c
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Dicerna Pharma (NASDAQ: DRNA) reported Q3 EPS of ($0.68), $0.17 better than the analyst estimate of ($0.85).
For earnings history and earnings-related data on Dicerna Pharma (DRNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald's (MCD) Tops Q4 EPS by 3c
- Expect Google (GOOGL) To Post A Strong Topline Q4 Report - Goldman Sachs
- Halliburton (HAL) Tops Q4 EPS by 3c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!